1. Home
  2. MMI vs ABCL Comparison

MMI vs ABCL Comparison

Compare MMI & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MMI

Marcus & Millichap Inc.

HOLD

Current Price

$29.58

Market Cap

1.2B

Sector

Finance

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$3.48

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MMI
ABCL
Founded
1971
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
MMI
ABCL
Price
$29.58
$3.48
Analyst Decision
Sell
Buy
Analyst Count
2
5
Target Price
$29.00
$7.75
AVG Volume (30 Days)
189.9K
5.2M
Earning Date
11-07-2025
11-06-2025
Dividend Yield
1.69%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$751,284,000.00
$35,325,000.00
Revenue This Year
$11.94
$16.99
Revenue Next Year
$15.59
$62.91
P/E Ratio
N/A
N/A
Revenue Growth
20.74
7.17
52 Week Low
$27.35
$1.89
52 Week High
$42.53
$6.52

Technical Indicators

Market Signals
Indicator
MMI
ABCL
Relative Strength Index (RSI) 51.09 34.15
Support Level $28.74 $3.42
Resistance Level $30.30 $3.78
Average True Range (ATR) 0.76 0.22
MACD 0.03 0.03
Stochastic Oscillator 62.33 36.45

Price Performance

Historical Comparison
MMI
ABCL

About MMI Marcus & Millichap Inc.

Marcus & Millichap Inc is a national brokerage firm specializing in commercial real estate investment sales, financing, research, and advisory services. The company offers three primary services to its clients: commercial real estate investment brokerage, financing, and ancillary services, including other research, advisory, and consulting services. The company generates revenues by collecting fees on the sale and financing of commercial properties. These fees consist of commissions collected upon the sale of a property and fees collected from the placement of loans.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: